Equities

Lumibird SA

Lumibird SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)6.90
  • Today's Change0.08 / 1.17%
  • Shares traded--
  • 1 Year change-45.92%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments566297
Total Receivables, Net544831
Total Inventory786546
Prepaid expenses------
Other current assets, total9.47128.93
Total current assets197187183
Property, plant & equipment, net484028
Goodwill, net737070
Intangibles, net595347
Long term investments111110
Note receivable - long term108.487.62
Other long term assets----0.00
Total assets405372348
LIABILITIES
Accounts payable181813
Accrued expenses------
Notes payable/short-term debt0.071.381.20
Current portion long-term debt/capital leases166413
Other current liabilities, total403631
Total current liabilities7412058
Total long term debt1294998
Total debt145114112
Deferred income tax1.852.580.87
Minority interest------
Other liabilities, total7.397.579.63
Total liabilities212179166
SHAREHOLDERS EQUITY
Common stock222222
Additional paid-in capital------
Retained earnings (accumulated deficit)172170157
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(1.58)1.071.46
Total equity193193181
Total liabilities & shareholders' equity405372348
Total common shares outstanding222222
Treasury shares - common primary issue0.040.030.02
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.